南天信息(000948) - 2015 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2015 was ¥307,625,638.85, representing a 25.15% increase compared to ¥245,803,223.17 in the same period last year[8]. - The net profit attributable to shareholders was -¥63,093,732.20, slightly worse than -¥58,098,264.15 in the previous year[8]. - The net cash flow from operating activities was -¥309,598,837.43, an improvement from -¥329,447,778.28 year-on-year[8]. - Operating revenue increased by ¥61.82 million, up 25.15%, while operating costs rose by ¥56.66 million, an increase of 27.28%, mainly due to significant growth in system integration and service business[18]. Assets and Liabilities - Total assets decreased by 12.11% to ¥2,290,531,550.70 from ¥2,606,244,687.27 at the end of the previous year[8]. - The net assets attributable to shareholders decreased by 4.45% to ¥1,353,785,627.13 from ¥1,416,879,359.33 at the end of the previous year[8]. - The company's cash and cash equivalents decreased by ¥425.32 million, a decline of 51.54%, primarily due to significant repayments of maturing loans and notes[17]. - Short-term borrowings decreased by ¥122.50 million, a decline of 44.46%, primarily due to repayments of maturing loans[17]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,581[12]. - The largest shareholder, Nantian Electronic Information Industry Group, held 28.64% of the shares, totaling 70,638,720 shares[12]. - There were no significant changes in the shareholding structure or any repurchase agreements among the top shareholders during the reporting period[14]. Cash Flow and Investments - The company reported non-recurring gains and losses totaling ¥664,313.54 for the period[9]. - The company’s investment income decreased by ¥2.67 million, a decline of 1064.44%, primarily due to reduced profits from invested unit Yunnan Pharmaceutical Industry Co., Ltd.[18]. - Cash received from tax refunds increased by ¥3.70 million, a rise of 100%, due to higher tax refund amounts received during the period[19]. - Cash received from other operating activities decreased by ¥38.30 million, down 76.15%, mainly due to a reduction in restricted funds released[19]. - Cash from the disposal of fixed assets increased by ¥6.00 million, up 7817.59%, due to higher proceeds from asset disposals compared to the previous year[19]. Accounts and Inventory - Accounts receivable increased by ¥72.50 million, up 18.95%, attributed to the industry characteristic of concentrated collections in the fourth quarter[17]. - Inventory rose by ¥53.59 million, an increase of 12.28%, driven by the need for procurement at the beginning of the year due to industry cycles[17]. - The company’s prepayments increased by ¥24.74 million, up 32.45%, mainly due to prepayments for the IBM project by its subsidiary[18]. Return on Assets - The weighted average return on net assets was -4.56%, compared to -4.22% in the same period last year[8].